Overall, our results demonstrated that RPPH1 functions as a tumour promoter and plays an important role in advancing tumorigenesis by targeting miR-122 and may serve as a novel and potential therapeutic, diagnostic or prognostic target in breast cancer. This evidence concerns the gene RPPH1 and breast carcinoma.